Clinical Trials Directory

Trials / Completed

CompletedNCT03134612

Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
104 (actual)
Sponsor
Indonesia University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the effectivity between ondansetron 8 mg and lidocain 40 mg in preventing pain due to propofol injection

Detailed description

Approval from Ethical Committee of Faculty of Medicine Universitas Indonesia was acquired prior conducting the study. Subjects were given informed consent before enrolling the study. Non-invasive blood pressure (NIBP) monitor, ECG and pulse-oximeter was set on the subjects in the operation room. After a tourniquet made from NIBP cuff were inflated, subjects were given either Ondansetron 8 mg or Lidocain 20 mg intravenously, then the tourniquet was set off. Hemodynamic data was recorded. Propofol 1 mg/kg of body weight (BW) injection was given. Verbal rating scale was used to measure pain at 0 s, 5 s and 30 s. Data was analyzed using Statistical Package for the Social Sciences (SPSS), for numeric data using uni-variate analysis and bi-variate analysis. Significant value is p\<0.05.

Conditions

Interventions

TypeNameDescription
DRUGOndansetron 8 mg
DRUGLidocain 40 mg

Timeline

Start date
2016-07-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2017-05-01
Last updated
2017-05-01

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT03134612. Inclusion in this directory is not an endorsement.